Presentation Information
[P1-057-C]IN-VITRO STABILITY OF THE ANTIGENS WHEN MIXING A NEW BIVALENT PCV2 AND MYCOPLASMA HYOPNEUMONIAE VACCINE WITH 2 INFLUENZA PRODUCTS
*Han Smits1, Nora Terenyi2, István Kiss2, Kathrin Lillie-Jaschniski1, Preben Mortensen1, Roman Krejci1 (1. Ceva Santé Animale (France), 2. Ceva Phylaxia (Hungary))
Keywords:
vaccine,mixing,PCV2,M. hyo,influenza